RxDoctor Payments Data

Rebecca Brady

Family · Alexandria, LANPI 1447944103

Payments from drug & device makers

$10,669in general payments, 2019–2025

Across 478 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • GSK$2K
  • Regeneron Healthcare Solutions, Inc.$897
  • Novartis$749
  • CSL Behring$605
  • Sanofi$546
  • plus $4K from 20 others

What the payments were for

  • Food & beverage$10,44198%
  • Education$2282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,669 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter306$222,895
Breo ElliptaFluticasone/Vilanterol91$38,981
Breztri AerosphereBudesonide/Glycopyr/Formoterol46$34,932
Spiriva RespimatTiotropium Bromide29$14,531
Epinephrine32$8,354
Fluticasone-SalmeterolFluticasone Propion/Salmeterol43$6,624
Azelastine Hcl158$4,837
SymbicortBudesonide/Formoterol Fumarate22$4,799
Albuterol Sulfate HfaAlbuterol Sulfate170$4,504
BreynaBudesonide/Formoterol Fumarate13$4,464
RyaltrisOlopatadine Hcl/Mometasone17$4,259
Azelastine-FluticasoneAzelastine/Fluticasone49$3,764
Advair HfaFluticasone Propion/Salmeterol11$3,169
Ipratropium Bromide91$2,353
Ventolin HfaAlbuterol Sulfate24$1,806

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$2,072$261,876397 claims
AstraZenecaBreztri Aerosphere, Symbicort$2,131$39,73168 claims
Hikma Pharmaceuticals USAEpinephrine, Ryaltris$256$12,61349 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,610 family providers in Louisiana.

Other family in Alexandria

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →